About Aakaar Medical Technologies Ltd
Aakaar Medical Technologies is to carry on the business of manufacturing and distribution of Medical equipment’s Cosmetic Medicines, all kinds and varieties of disposable and non-disposable surgical instruments, Medical Devices, kits to provide treatment in any medical specialty, and to buy, sell, manufacture, import, export, distribute, repair, service and otherwise deal in all kinds and varieties of cosmetics, non-prescribed drugs, health care products, health aids, glamour products.
Founded
2013
CEO
Bindi Dilip Meswani
Employees
268
HQ
Mumbai, Maharashtra
Finished Products
1Sale of Traded Goods
₹184.64Cr2Sale of Goods
₹22.33Cr3Service Income
₹0.38Cr4AMC Income
₹0.08Cr5CMC Income
₹0.01Cr6Repair Income
₹0.01CrRaw Materials
1Purchase of Traded goods
₹93.32Cr2Raw Materials Consumed
₹9.81CrAbout Aakaar Medical Technologies Ltd
Aakaar Medical Technologies is to carry on the business of manufacturing and distribution of Medical equipment’s Cosmetic Medicines, all kinds and varieties of disposable and non-disposable surgical instruments, Medical Devices, kits to provide treatment in any medical specialty, and to buy, sell, manufacture, import, export, distribute, repair, service and otherwise deal in all kinds and varieties of cosmetics, non-prescribed drugs, health care products, health aids, glamour products.
Founded:2013
CEO:Bindi Dilip Meswani
Employees:268
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Traded Goods
₹184.64Cr2Sale of Goods
₹22.33Cr3Service Income
₹0.38Cr4AMC Income
₹0.08Cr5CMC Income
₹0.01Cr6Repair Income
₹0.01CrRaw Materials
1Purchase of Traded goods
₹93.32Cr2Raw Materials Consumed
₹9.81CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹96
52W Low
₹46
Volume11.20K
Avg VolumeN/A
Beta0.26
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
13.57x
Valuation
P/B Ratio
1.65x
Valuation
EPS
₹4.68
Valuation
Dividend Yield
0.00%
Valuation
ROE
12.17%
Profitability
ROCE
15.03%
Profitability
Revenue by Segment
Contribution & growth by business line
Aesthetic Products
+12.4%89.0%
₹59.608 Cr
Aesthetic Devices & Device consumab
-13.9%11.0%
₹7.357 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.34x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
13.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.